Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma

DSpace Repository

Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma

Author: Ruf, Benjamin
Tübinger Autor(en):
Ruf, Benjamin
Other Contributors: Eberhard Karls Universität Tübingen
Issue year: 2017
Verlagsangabe: Tübingen
Language: English
Full text: http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-790589
DDC Classifikation: 610 - Medicine and health
Dokumentart: Dissertation
Pages: III, 120 Seiten : Illustrationen
Reference: 496063952
496063022
Note: Dissertation, Eberhard Karls Universität Tübingen, 2017; Erscheint auch als, Online-Ausgabe, Ruf, Benjamin, Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma, Tübingen, 2017, 1 Online-Ressource (III, 118 Seiten),
Show full item record

This item appears in the following Collection(s)